by: MSN
by: Thomas Matters
This ASX healthcare stock is up 160% in a month! Here's why it's just entered a trading halt
by: Thomas Matters
The Cost Of Euphoria: Why Palantir's Rally Could Be A Mirage
Palantir's impressive quarterly results and growth rates are overshadowed by the unrealistic expectations for future FCF growth. Read why PLTR stock is a Sell.

Read the Full Seeking Alpha Article at:
https://seekingalpha.com/article/4742233-cost-of-euphoria-why-palantir-stock-rally-may-be-mirage-reiterate-sell
on: Wed, Dec 04th 2024
by: Thomas Matters
Earnings On The Rise: 25 Stocks With Largest Upward Revisions To Consensus Estimates
on: Wed, Dec 04th 2024
by: Thomas Matters
Tactical Sell Call On BigBear.ai Holdings: Take The Market Gift And Move On
on: Wed, Dec 04th 2024
by: Thomas Matters
Is easyJet's share price set to soar after strong 2024 results and upbeat business projections?
on: Tue, Dec 03rd 2024
by: Thomas Matters
on: Tue, Dec 03rd 2024
by: Thomas Matters
Vitasoy International: Turning Bullish On Margin Expansion And Shareholder Stake Increase
on: Tue, Dec 03rd 2024
by: Thomas Matters
A 7% dividend yield but down 16%! Is this mining giant a no-brainer?
on: Sun, Dec 01st 2024
by: Thomas Matters
Better Artificial Intelligence Stock: SoundHound vs. Palantir
on: Fri, Nov 29th 2024
by: Thomas Matters
Better Artificial Intelligence Stock: Palantir Technologies vs. IBM
on: Thu, Nov 28th 2024
by: Thomas Matters
